Skip to main content

Table 2 Differential miRNA expression between groups in CSF

From: Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions

  Gd (n = 20) Gd + (n = 26)  
Median Q1-Q3 Median Q1–Q3 p value
miR-21 0.014 0.010–0.022 0.029 0.013–0.052 0.024
miR-146a 0.065 0.031–0.136 0.135 0.082–0.239 0.016
miR-146b 0.008 0.002–0.020 0.021 0.012–0.052 0.030
miR-155 0.007 0.002–0.016 0.011 0.006–0.019 0.163
miR-223 0.066 0.043–0.328 0.124 0.088–0.226 0.232
miR-320 0.038 0.010–0.048 0.042 0.026–0.087 0.271
miR-328 0.007 0.003–0.012 0.011 0.005–0.026 0.143
  1. Gd− patients without gadolinium-enhanced lesions, Gd+ patients with gadolinium-enhanced lesions; Q1–Q3 first quartile–third quartile